20 julio 2015
Scientists have evidence that monoclonal antibodies they developed may provide the blueprint for effective treatments for Alzheimer’s disease and other neurodegenerative diseases, such as Parkinson’s disease.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/GOTh3NliRdw» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/GOTh3NliRdw/150720154218.htm
